| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.309 | 5.386 | 8.700 | 18.034 | 15.210 | 1.480 | 0 | 0 |
| Total Income - EUR | - | - | 1.309 | 5.386 | 8.700 | 18.638 | 15.210 | 2.689 | 0 | 121 |
| Total Expenses - EUR | - | - | 318 | 8.191 | 17.485 | 17.434 | 18.381 | 2.489 | 2.353 | 4.470 |
| Gross Profit/Loss - EUR | - | - | 992 | -2.806 | -8.784 | 1.204 | -3.172 | 200 | -2.353 | -4.349 |
| Net Profit/Loss - EUR | - | - | 952 | -2.967 | -9.043 | 1.027 | -3.432 | 120 | -2.353 | -4.349 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Biolid Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 152 | 1.431 | 13.104 | 11.075 | 9.089 | 7.371 | 5.607 | 3.845 |
| Current Assets | - | - | 1.103 | 3.357 | 4.501 | 10.100 | 5.623 | 4.006 | 3.360 | 683 |
| Inventories | - | - | 0 | 2.106 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 302 | 803 | 2.061 | 4.256 | 3.826 | 3.152 | 2.172 | 0 |
| Cash | - | - | 801 | 449 | 2.440 | 5.844 | 1.797 | 854 | 1.187 | 683 |
| Shareholders Funds | - | - | 996 | -1.989 | -10.994 | -9.717 | -12.934 | -12.855 | -15.168 | -19.432 |
| Social Capital | - | - | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 258 | 6.777 | 28.605 | 30.893 | 27.703 | 24.232 | 24.135 | 23.960 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Biolid Medical Srl